Skip to main content
Traumatic Brain InjuryDiagnostics and screeningHealthy volunteersBrain and nervesDrugEarly Phase 1

What this study is

This project is to evaluate sensitivity and specificity of hyperpolarized 13C-pyruvate as imaging agents of altered cerebral glycolysis and mitochondrial dysfunction and assess pyruvate utilization in mitochondria in Traumatic Brain Injury (TBI) patients.

What's being tested

  • Hyperpolarized [1-13C] Pyruvate

    Intervention · DRUG

  • Hyperpolarized [2-13C] Pyruvate

    Intervention · DRUG

Both interventions

Bolus injection of study drug

Study details

Sponsor
University of Texas Southwestern Medical Center
Conditions
Traumatic Brain Injury
Enrolling
60 people
Starts
2018-06-01
Est. completion
2026-12-30
Design
Open-label, non-randomized, parallel groups, Early Phase 1
Record
View on ClinicalTrials.gov ↗